本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

BIODEXA PHARMACEUTICALS PLC SPON ADS EACH REP 5 ORD

0.8446
-0.0074-0.87%
盤後0.8400-0.0046-0.54%19:59 EDT
成交量:36.60萬
成交額:31.72萬
市值:426.57萬
市盈率:-0.06
高:0.9052
開:0.8550
低:0.8220
收:0.8520
資料載入中...
2025/04/11

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2025/01/24

SEC問詢函

Form CORRESP - Correspondence
2025/01/17

招股説明書

Form F-1 - Registration statement for certain foreign private issuers
2024/11/20

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/13

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/07

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/08/16

SEC問詢函

Form CORRESP - Correspondence
2024/08/12

招股説明書

Form F-1 - Registration statement for certain foreign private issuers
2024/08/09

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/07/23

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/06/12

SEC問詢函

Form CORRESP - Correspondence
2024/06/06

招股説明書

Form F-1 - Registration statement for certain foreign private issuers
2024/04/19

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/03/21

SEC問詢函

Form CORRESP - Correspondence
2024/03/18

招股説明書

Form F-1 - Registration statement for certain foreign private issuers
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]